These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28495148)

  • 1. Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer.
    Barrabés S; Llop E; Ferrer-Batallé M; Ramírez M; Aleixandre RN; Perry AS; de Llorens R; Peracaula R
    Clin Chim Acta; 2017 Jul; 470():97-102. PubMed ID: 28495148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.
    Llop E; Ferrer-Batallé M; Barrabés S; Guerrero PE; Ramírez M; Saldova R; Rudd PM; Aleixandre RN; Comet J; de Llorens R; Peracaula R
    Theranostics; 2016; 6(8):1190-204. PubMed ID: 27279911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen.
    Kammeijer GSM; Nouta J; de la Rosette JJMCH; de Reijke TM; Wuhrer M
    Anal Chem; 2018 Apr; 90(7):4414-4421. PubMed ID: 29502397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns.
    Janković MM; Kosanović MM
    Clin Biochem; 2005 Jan; 38(1):58-65. PubMed ID: 15607318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer.
    Fujita K; Hayashi T; Matsuzaki K; Nakata W; Masuda M; Kawashima A; Ujike T; Nagahara A; Tsuchiya M; Kobayashi Y; Nojima S; Uemura M; Morii E; Miyoshi E; Nonomura N
    Oncotarget; 2016 Aug; 7(35):56643-56649. PubMed ID: 27494861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.
    Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J
    J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
    Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
    Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
    Llop E; Peracaula R
    Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia.
    Dwek MV; Jenks A; Leathem AJ
    Clin Chim Acta; 2010 Dec; 411(23-24):1935-9. PubMed ID: 20708609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.
    Hatano K; Yoneyama T; Hatakeyama S; Tomiyama E; Tsuchiya M; Nishimoto M; Yoshimura K; Miyoshi E; Uemura H; Ohyama C; Nonomura N; Fujita K
    Br J Cancer; 2022 Mar; 126(5):764-770. PubMed ID: 34802050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
    Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
    Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
    Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
    [No Abstract]   [Full Text] [Related]  

  • 13. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
    Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.
    Ferrer-Batallé M; Llop E; Ramírez M; Aleixandre RN; Saez M; Comet J; de Llorens R; Peracaula R
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of the main PSA glycoforms in aggressive prostate cancer.
    Gratacós-Mulleras A; Duran A; Asadi Shehni A; Ferrer-Batallé M; Ramírez M; Comet J; de Llorens R; Saldova R; Llop E; Peracaula R
    Sci Rep; 2020 Nov; 10(1):18974. PubMed ID: 33149259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum core-type fucosylated prostate-specific antigen index for the detection of high-risk prostate cancer.
    Fujita K; Hatano K; Tomiyama E; Hayashi Y; Matsushita M; Tsuchiya M; Yoshikawa T; Date M; Miyoshi E; Nonomura N
    Int J Cancer; 2021 Jun; 148(12):3111-3118. PubMed ID: 33594666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialylation and fucosylation of cancer-associated prostate specific antigen.
    Kosanović MM; Janković MM
    J BUON; 2005; 10(2):247-50. PubMed ID: 17343337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development and Clinical Application of Glycan-Targeted Biomarkers for Prostate Cancer].
    Ohyama C; Yoneyama T; Tobisawa Y; Ishikawa T; Hatakeyama S; Koie T; Mori K
    Rinsho Byori; 2017 Feb; 65(2):210-217. PubMed ID: 30762989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer.
    Vermassen T; Van Praet C; Vanderschaeghe D; Maenhout T; Lumen N; Callewaert N; Hoebeke P; Van Belle S; Rottey S; Delanghe J
    Electrophoresis; 2014 Apr; 35(7):1017-24. PubMed ID: 24254641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.